Duncan Park Holdings Corporation Announces Non-Brokered Private Placement of Common Shares
Toronto, Ontario – May 12, 2020 – Duncan Park Holdings Corporation (the “Company“) announces that it has undertaken to complete a non-brokered private placement (the “Offering“) of up to 20,000,000 common shares of the Company (each a “Common Share“) to be issued at a price of $0.10 per Common Share, for gross proceeds of up to $2,000,000.
The proceeds from the Offering will be used for establishing new business lines and general working capital.
In connection with the Offering, the Company may pay certain qualified persons (i) a finder’s fee equal to 8% on the proceeds from subscribers referred by the applicable finder, and (ii) a number of finder warrants (each, a “Finder Warrant“) equal to 8% of the number of Common Shares issued to subscribers referred by the finder. Each Finder Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of $0.10 per Common Share, for a period of 24 months following the issuance of the Finders Warrants.
All securities issued as part of the Offering are subject to a statutory four-month and one day hold period from their issue date.
The Company also announced today that it has filed a notice of meeting for an annual and special meeting of shareholders of the Company to be held on June 30, 2020. It is anticipated that at the meeting, in addition to the election of directors and the appointment of auditors, the Company will seek approval of a new stock option plan and an amendment to the Company’s articles to change its name to “Psyched Wellness Ltd.” or such other name as the directors of the Company deem advisable. The name change is being proposed in connection with the completion by the Company of the purchase of all of the issued and outstanding shares of Psyched Wellness Corp. (“Psyched“) and the intention of the Company to conduct the business of Psyched moving forward, all as disclosed in the Company’s press release dated May 5, 2020.
“This financing is a key milestone for the Company as it will provide enough runway to complete the R&D and move towards a minimum viable product (MVP) for our initial product, an amanita muscaria mushroom tincture. We look forward to holding the annual and special meeting of the shareholders on June 30, 2020 to move the Company forward with the support of our shareholders,” says Jeff Stevens, CEO of the Company.
About Duncan Park Holdings Corporation
The Company is the parent company of Psyched which is a Canadian-based health supplements company dedicated to the production and distribution of artisanal functional mushrooms and associated consumer packaged goods.
For more information, please contact
Chief Executive Officer
Duncan Park Holdings Corporation
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements in this press release include statements relating to the closing of the Offering and the timing thereof, the amount that will be raised and the use of such proceeds. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward- looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.